We use some essential cookies to make this website work.
We鈥檇 like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in human samples in England.
Help us improve this resource We鈥檇 like your feedback on how you use these鈥�
Main messages Main messages from this report are as follows: Between鈥�
Main messages Main messages from this report are as follows: 皇冠体育app quarterly鈥�
Main messages Main messages from this report are as follows: the quarterly鈥�
Background Since 1 October 2020, all diagnostic laboratories in England鈥�
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.
Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).
Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection (CDI) reported by independent sector healthcare organisations, with accompanying commentary. Official statistics 鈥�
Voluntary surveillance of streptococcal bacteraemia in England.
Notifications of scarlet fever disease in England and data from invasive group A streptococci (iGAS) surveillance.
Annual report and data tables showing frequency of bloodstream infections in critical care units in England, the microbes that cause them, and linked factors.
Voluntary surveillance of paediatric bacteraemia in England.
This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres.
皇冠体育app ESPAUR report includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation, and awareness activities.
Annual reports on voluntary surveillance of fungaemia (blood infections due to yeast species) in England.
Trends in ribotypes of Clostridioides difficile (C. difficile) and research into the increased frequency of C. difficile infections (CDI).
皇冠体育app number of infections of Escherichia coli (E. coli) O157 reported in England and Wales for 2019 and 2020, and England only from 2021 onwards.
Trends in voluntary reports of Enterococcus spp. by age, sex and geographical distribution in England.
MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostridioides difficile infections (CDI) by organisation and prior trust exposure.
National influenza (flu) and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Monitors the number of people who visit their GP during surgery hours under the syndromic surveillance system.
Don鈥檛 include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we鈥檇 like to know more about your visit today. .